Gold inches higher on softer dollar, virus woes; vaccine hopes cap gains
· Gold prices edged higher on Tuesday as dollar slipped, while investors weighed concerns over spiking coronavirus cases globally against optimism over positive developments around a second possible Covid-19vaccine.
· Spot gold rose 0.1% to $1,890.27 per ounce by 0327 GMT, while U.S. gold futures were up 0.1% at $1,889.70.
· Bullion dropped as much as 1.3% on Monday after drugmaker Moderna said its experimental vaccine was 94.5% effective in preventing Covid-19 based on interim data from a late-stage trial, becoming the second U.S. drugmaker after Pfizer to report results exceeding expectations.
· “Traders are striking a balance between the positive vaccine breakthrough and the prospect of lower fiscal stimulus in the quarters to come,” said Margaret Yang, strategist, DailyFX.
But monetary environment is still very accommodative and may stay at current levels into spring of 2021 providing near-term support for gold prices, she added.
· Gold, considered a hedge against inflation and currency debasement, has gained over 24% this year, mainly benefiting from global stimulus measures to cushion the effect of the pandemic.
· Silver fell 0.1% to $24.73 per ounce. Platinum eased 0.5% to $920.56, while palladium was down 0.2% at $2,327.39.
Reference: CNBC